<DOC>
	<DOCNO>NCT00181636</DOCNO>
	<brief_summary>The purpose study determine whether investigational drug galantamine-CR ( Reminyl- Controlled Release capsule ) useful improve problem memory bipolar patient stable mood . This study do large proportion patient bipolar disorder experience significant memory problem , even mood stable , adequate treatment . These memory problem associate poor daily social functioning . Studying galantamine-CR population may provide new clinical way combat memory problem stable patient bipolar disorder .</brief_summary>
	<brief_title>Galantamine-CR Cognitive Dysfunction Bipolar Disorder</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<criteria>DSMIV diagnostic criterion bipolar disorder men woman age 1865 baseline HamiltonD17 score &lt; 10 screen visit baseline YMRS score &lt; 10 screen visit acute episodes depression mania previous 12 week . write informed consent Subjects current suicidal ideation Pregnant woman woman childbearing potential Serious unstable medical illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurologic hematologic disease ; History seizure disorder , brain injury , history know neurological disease ( multiple sclerosis , degenerative disease ALS , Parkinson disease movement disorder , etc ) History current diagnosis follow DSMIV psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , major depressive disorder , patient mood congruent mood incongruent psychotic feature , patient substance dependence disorder , include alcohol , active within last 12 month History multiple adverse drug reaction Patients mood congruent mood incongruent psychotic feature Subjects active smoker stop smoke less 3 month prior enrollment ; Clinical laboratory evidence hypothyroidism Patients episode acute depression mania 12 week prior enrollment Patients electroconvulsive therapy ( ECT ) within 6 month precede enrollment Patients physical contraindication magnetic resonance spectroscopy ( ferrous surgical clip , cardiac pacemaker , ferrous prosthesis ) Patients take follow medication : cholinesterase inhibitor , succinylcholine , neuromuscular block agent , cholinergic agonist ( e.g. , bethanechol ) , cimetidine , ketoconazole , erythromycin , fluoxetine , paroxetine , fluvoxamine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>